Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response

Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response

US Patent 11124768 · Granted Sep 21, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Generation of dendritic cells from monocytic dendritic precursor cells with GM-C2023
Generation of dendritic cells from monocytic dendritic precursor cells with GM-C2020
Generation of dendritic cells from monocytic dendritic precursor cells with GM-C2015
Tangential flow filtration devices and methods for leukocyte enrichment2013
Generation of dendritic cells from monocytic dendritic precursor cells with GM-C2013
Tangential flow filtration devices and methods for stem cell enrichment2010
Tangential flow filtration devices and methods for leukocyte enrichment2010
Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses2000
Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses2000
DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retr1999
Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses1999